Evaluation of the Hypolipidemic Effect of Bergavit by a Human Trial.

Inclusion Criteria: * 1 Healthy men and women (40-70 years old); * 2 Asian subjects with LDL-cholesterol (ranging from 100 to 159; see here below) * 3 Subjects naïve to statins or other treatment and food supplement that can interfere with the study treatment for the previous 1 month * 4 Reading, understanding and signed approval of the informative consent * 5 No vegetarian. Subjects who will continue, expect reserve, their normal lifestyle * 6 Healthy volunteers without clinical illness diagnosed with relevant effect on the gastrointestinal system or the motility visceral Exclusion Criteria: * 1 Subjects \<40 and \>70 years old * 2 Clinical history with relevant presence of any disorder or administration of drugs/food supplement that can potentially interfere with the treatment under study * 3 lack of compliance defined as not using the correct Bergavit dose or placebo for\>1 week), and inability to give informed consent * 4 Subjects who have changed their diet significantly or have been placed on weight reduction products * 5 Smokers, Obesity subjects, during breast feeding * 6 Changing the eating habits within the 2 weeks previous the screening * 7 During the pregnancy of the subjects or of the subjective planning of the study * 8 Subjects with a history of drug, alcohol and other substance abuse * 9 Known food intolerance or food allergy * 10 Subjects involved in a clinical or food study within the previous month * 11 Subjects who have unstable medical diseases (cardiac arrhythmias or ischemia, uncontrolled hypertension and hypotension, diabetes mellitus, kidney failure) * 12 Subjects with a history of paralysis or cerebral vascular accident * 13 Subjects with active cancers or on chemotherapy